Most are approved to treat Type 2 diabetes, while others are specifically approved for weight loss
As patients on GLP-1 receptor agonists, a new class of anti-obesity medicines, face the risk of micronutritional loss, these supplements are being prescribed by clinicians to make up for the deficit.According to Pharmarack, which tracks major Indian pharmaceuticals, the sales of vitamin supplements increased by 11.6% in April (Rs 871.85 crore) compared to March (Rs 780.57 crore)
A 2023 review in Archives of Physiology and Biochemistry found that berberine stimulates GLP-1 secretion by modulating gut microbiota and influencing insulin signaling pathways
In plasma the level of GHK is about 200 ng/mL at age 20 but declines to 80 ng/mL by age 60. [5] Empire Medical Training (2026)
Retatrutide Therapy in Miami Target three metabolic pathways with retatrutide a next-generation triple-agonist peptide activating GLP-1, GIP, and glucagon receptors, with some of the strongest weight-loss results reported in clinical trials to date
For information on additional studies that will open in the future, please visit our upcoming studies page
